Fred Schreiber

667 total citations
19 papers, 365 citations indexed

About

Fred Schreiber is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fred Schreiber has authored 19 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Fred Schreiber's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Economic and Financial Impacts of Cancer (3 papers). Fred Schreiber is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Economic and Financial Impacts of Cancer (3 papers). Fred Schreiber collaborates with scholars based in United States and United Kingdom. Fred Schreiber's co-authors include Jhanelle E. Gray, Thomas H. Cartwright, Richard M. Levine, Ji‐Hyun Lee, Mokenge P. Malafa, R. H. Brown, William J. Fulp, Paul B. Jacobsen, Merry Jennifer Markham and Tawee Tanvetyanon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of the American College of Surgeons.

In The Last Decade

Fred Schreiber

19 papers receiving 349 citations

Peers

Fred Schreiber

ONCOL

PRM

PHEOH

Pearl H. Seo United States

Lisel Koepl United States

D. Greenberg United Kingdom

P Silcocks United Kingdom

Natalie R. Dickson United States

S.J. Brenninkmeijer Netherlands

Emmanuelle Kempf France

Rachel Dear Australia

Rori Salvaggio United States

Richard Lee United States

Pearl H. Seo United States

Fred Schreiber

256 ×1.4

ONCOL

82 ×0.6

PRM

56 ×0.6

PHEOH

116 ×1.6

161 ×2.4

Citations per year, relative to Fred Schreiber Fred Schreiber (= 1×) peers Pearl H. Seo

Countries citing papers authored by Fred Schreiber

Since Specialization

Citations

This map shows the geographic impact of Fred Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Schreiber more than expected).

Fields of papers citing papers by Fred Schreiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Schreiber. The network helps show where Fred Schreiber may publish in the future.

Co-authorship network of co-authors of Fred Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Schreiber. A scholar is included among the top collaborators of Fred Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Schreiber. Fred Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Tanvetyanon, Tawee, Ji‐Hyun Lee, William J. Fulp, et al.. (2015). Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non–Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care. Journal of Oncology Practice. 11(4). 332–337. 4 indexed citations

Jacobsen, Paul B., Ji‐Hyun Lee, William J. Fulp, et al.. (2015). Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval. Journal of Oncology Practice. 11(1). e103–e109. 6 indexed citations

Laronga, Christine, Jhanelle E. Gray, Erin M. Siegel, et al.. (2014). Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval. Journal of the American College of Surgeons. 219(4). 638–645e1. 12 indexed citations

Tanvetyanon, Tawee, Ji‐Hyun Lee, William J. Fulp, et al.. (2014). Changes in the Care of Non–Small-Cell Lung Cancer After Audit and Feedback: The Florida Initiative for Quality Cancer Care. Journal of Oncology Practice. 10(4). e247–e254. 11 indexed citations

Bepler, Gerold, Charles C. Williams, Michael J. Schell, et al.. (2013). Molecular analysis-directed, international, phase III trial in patients with advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 31(15_suppl). 8001–8001. 3 indexed citations

Bepler, Gerold, Charles C. Williams, Michael J. Schell, et al.. (2013). Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 31(19). 2404–2412. 108 indexed citations

Jacobsen, Paul B., Kristen J. Wells, Cathy D. Meade, et al.. (2012). Effects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicenter Randomized Controlled Trial. Journal of Clinical Oncology. 30(20). 2516–2521. 52 indexed citations

Tanvetyanon, Tawee, Ji‐Hyun Lee, William J. Fulp, et al.. (2011). Quality of Care in Non–Small-Cell Lung Cancer: Findings From 11 Oncology Practices in Florida. Journal of Oncology Practice. 7(6). e25–e31. 10 indexed citations

Gray, Jhanelle E., Christine Laronga, Erin M. Siegel, et al.. (2011). Degree of Variability in Performance on Breast Cancer Quality Indicators: Findings From the Florida Initiative for Quality Cancer Care. Journal of Oncology Practice. 7(4). 247–251. 16 indexed citations

10.

Jacobsen, Paul B., David Shibata, Erin M. Siegel, et al.. (2010). Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators. Psycho-Oncology. 20(11). 1221–1227. 47 indexed citations

11.

Yardley, Denise A., Michael McCleod, Fred Schreiber, et al.. (2010). A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer. Cancer Investigation. 28(9). 925–931. 17 indexed citations

12.

Extermann, Martine, I. Boler, Richard R. Reich, et al.. (2010). The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation.. Journal of Clinical Oncology. 28(15_suppl). 9000–9000. 29 indexed citations

13.

Yardley, DA, et al.. (2009). Final results of a first line multicenter phase II metastatic breast cancer trial of vinflunine monotherapy and in combination with trastuzumab in HER2+ patients.. Cancer Research. 69(2_Supplement). 3148–3148. 3 indexed citations

14.

Schreiber, Fred, et al.. (2007). Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy. Urologic Oncology Seminars and Original Investigations. 25(4). 284–290. 9 indexed citations

15.

Peacock, N. W., David R. Spigel, Mark Mainwaring, et al.. (2007). Preliminary results of a multicenter phase II trial of vinflunine (with trastuzumab in HER2+ pts) as first-line treatment in metastatic breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1043–1043. 12 indexed citations

16.

Schreiber, Fred, et al.. (1983). The Estiennes: An Annotated Catalogue of 300 Highlights of Their Various Presses.. 6 indexed citations

17.

Schreiber, Fred, et al.. (1978). A Bibliography of Petronius. The Classical World. 72(1). 55–55. 2 indexed citations

18.

Schreiber, Fred, et al.. (1976). Storia di una commedia di Atene. The American Journal of Philology. 97(1). 79–79. 2 indexed citations

19.

Schreiber, Fred, et al.. (1975). Aristophanes, Ecclesiazusae. The American Journal of Philology. 96(3). 308–308. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact